// App-Quantinova.ai

P151 : Rationalizing colonoscopy utilization for Inflammatory bowel disease diagnosis: time to reset the Calprotectin threshold to >600?

Researchers

Presenter

  • Desoki, R

Principal Investigators

  • Abdellah Ahmed, M

  • Taylor, K

  • Woodward, J

  • Corbett, G

  • Parkes, M

Medical Centers

  • Addenbrookes Hospital - Cambridge University Hospitals NHS FT, Gastroenterology, Cambridge, United Kingdom

  • Alexandria University Hospital, Alexandria, Egypt

  • Al-Azhar University, Internal Medicine, Cairo, Egypt

  • Addenbrookes Hospital - Cambridge University Hospitals NHS FT, Endocrine Laboratory- Blood Sciences., Cambridge, United Kingdom

Locations

  • United Kingdom

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Genetic Disorder

  • Gastroenterology (GU)

  • Oncology (ONC)

Disease

  • Inflammatory bowel disease

  • Microscopic colitis

  • Ulcerative colitis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved